Utility of ICG in Benign Bone Tumors
NCT05075889
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class
Conditions
Bone Tumor
Interventions
DRUG:
Indocyanine Green
Sponsor
Dartmouth-Hitchcock Medical Center